2004
DOI: 10.1126/science.1093933
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice

Abstract: Because ethical restrictions limit in vivo studies of the human hemato-lymphoid system, substitute human to small animal xenotransplantation models have been employed. Existing models, however, sustain only limited development and maintenance of human lymphoid cells and rarely produce immune responses. Here we show that intrahepatic injection of CD34+ human cord blood cells into conditioned newborn Rag2-/-gammac-/- mice leads to de novo development of B, T, and dendritic cells; formation of structured primary … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

38
997
1
6

Year Published

2007
2007
2018
2018

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 904 publications
(1,042 citation statements)
references
References 23 publications
38
997
1
6
Order By: Relevance
“…The challenge was repeated once after 6 days. The hu-thym-SCID chimaeras were maintained for 4 weeks (unless otherwise stated) (22). In some cases, CD4 + or/and CD8 + NKT cells (1  10 5 cells/mouse) were purified from thymi of EBV-exposed hu-thym-SCID chimaeras (at week 4 post-establishment), mixed with syngeneic CD3 + CD56 -CD161 -T cells (2  10 6 cells/mouse) purified from the spleens of EBV-exposed hu-thym-SCID chimaeras and antigen presenting cells (DCs, 0.5  10 6 cells/mouse), and i.v.…”
Section: Human-thymus-scid Chimaeras and Humanised Xenogeneic Tumour-mentioning
confidence: 99%
“…The challenge was repeated once after 6 days. The hu-thym-SCID chimaeras were maintained for 4 weeks (unless otherwise stated) (22). In some cases, CD4 + or/and CD8 + NKT cells (1  10 5 cells/mouse) were purified from thymi of EBV-exposed hu-thym-SCID chimaeras (at week 4 post-establishment), mixed with syngeneic CD3 + CD56 -CD161 -T cells (2  10 6 cells/mouse) purified from the spleens of EBV-exposed hu-thym-SCID chimaeras and antigen presenting cells (DCs, 0.5  10 6 cells/mouse), and i.v.…”
Section: Human-thymus-scid Chimaeras and Humanised Xenogeneic Tumour-mentioning
confidence: 99%
“…The recent advances in the development of HIS mice provide a new model to experimentally dissect human lymphocyte biology that may eventually allow us to bridge the knowledge gap between murine and human in vivo studies of immune responses. One welldescribed HIS mouse model involves engraftment of newborn Balb/c Rag2 À/À g c À/À mice with human fetal liver or cord blood haematopoietic stem cells (HSCs), which seed the murine BM and thymus and in turn differentiate into an almost complete spectrum of mature human myeloid and lymphoid cell subsets [1][2][3]. Human B-cell development predominates in this model, with T cells encompassing o10% of the peripheral lymphocyte pool [1][2][3].…”
Section: Introductionmentioning
confidence: 99%
“…One welldescribed HIS mouse model involves engraftment of newborn Balb/c Rag2 À/À g c À/À mice with human fetal liver or cord blood haematopoietic stem cells (HSCs), which seed the murine BM and thymus and in turn differentiate into an almost complete spectrum of mature human myeloid and lymphoid cell subsets [1][2][3]. Human B-cell development predominates in this model, with T cells encompassing o10% of the peripheral lymphocyte pool [1][2][3]. The reasons for the reduced T-cell homeostasis is not known, but could involve central and/or peripheral mechanisms.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations